☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Pyxis Oncology
Pyxis Oncology In-Licenses BSI-060T From Biosion for the Treatment of Solid Tumors
March 30, 2022
PharmaShots Interview: Pyxis Oncology's Dr. Lara S. Sullivan and Dr. Ronald Herbst Share Insights on the Importance of Series B Fu...
April 26, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.